Crossref


2. Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials

- Senri Yamamoto

- Hirotoshi Iihara

- Ryuji Uozumi

- Hitoshi Kawazoe

- Kazuki Tanaka

- Yukiyoshi Fujita

- Masakazu Abe

- Hisao Imai

- Masato Karayama

- Yoh Hayasaki

- Chiemi Hirose

- Takafumi Suda

- Kazuto Nakamura

- Akio Suzuki

- Yasushi Ohno

- Ken-ichirou Morishige

- Naoki Inui

3. Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis

- Daichi Watanabe

- Hirotoshi Iihara

- Ryo Kobayashi

- Hironori Fujii

- Ryutaro Mori

- Keisuke Kumada

- Masahito Shimizu

- Manabu Futamura

- Akio Suzuki